From Wikipedia, the free encyclopedia
Jump to: navigation, search
Abbreviated title (ISO 4)
Med. Chem. Commun.
Discipline Chemistry, medicine
Language English
Edited by Anthony Wood, Greg Verdine
Publication details
Royal Society of Chemistry (United Kingdom)
Publication history
Frequency Monthly
ISSN 2040-2503 (print)
2040-2511 (web)
LCCN 2011243017
OCLC no. 663378788

MedChemComm (in full: Medicinal Chemistry Communications) is a peer-reviewed scientific journal publishing original (primary) research and review articles on all aspects of medicinal chemistry, including drug discovery, pharmacology and pharmaceutical chemistry. It is published monthly by the Royal Society of Chemistry in partnership with the European Federation for Medicinal Chemistry, of which it is the official journal. Authors can elect to have accepted articles published as open access.[1] According to the Journal Citation Reports, the journal has a 2014 impact factor of 2.495, ranking it 27th out of 59 journals in the category "Chemistry, Medicinal"[2] and 163 out of 289 journals in the category "Biochemistry & Molecular Biology".[3]

The editors-in-chief are Anthony Wood (Pfizer, USA) and Greg Verdine (Harvard University).[4]

Article types[edit]

MedChemComm publishes Concise Articles (original scientific work, 3-7 pages in length) and Reviews (critical analyses of specialist areas).[4]


  1. ^ "RSC Open Science". Royal Society of Chemistry. 2006-10-01. Retrieved 2012-07-07. 
  2. ^ "Journals Ranked by Impact: Chemistry, Medicinal". 2014 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2015.  (subscription required)
  3. ^ "Journals Ranked by Impact: Biochemistry & Molecular Biology". 2014 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2015.  (subscription required)
  4. ^ a b "About MedChemComm". Royal Society of Chemistry. Retrieved 2012-07-07. 

External links[edit]